DK0946590T3 - Dihydroxypropylcysteinpeptid og middel, der indeholder dette peptid - Google Patents

Dihydroxypropylcysteinpeptid og middel, der indeholder dette peptid

Info

Publication number
DK0946590T3
DK0946590T3 DK97954818T DK97954818T DK0946590T3 DK 0946590 T3 DK0946590 T3 DK 0946590T3 DK 97954818 T DK97954818 T DK 97954818T DK 97954818 T DK97954818 T DK 97954818T DK 0946590 T3 DK0946590 T3 DK 0946590T3
Authority
DK
Denmark
Prior art keywords
peptide
dihydroxypropylcysteine
agent containing
relates
dihydroxypropyl
Prior art date
Application number
DK97954818T
Other languages
English (en)
Inventor
Peter F Muehlradt
Original Assignee
Biotechnolog Forschung Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnolog Forschung Gmbh filed Critical Biotechnolog Forschung Gmbh
Application granted granted Critical
Publication of DK0946590T3 publication Critical patent/DK0946590T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97954818T 1996-12-17 1997-12-17 Dihydroxypropylcysteinpeptid og middel, der indeholder dette peptid DK0946590T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19652586A DE19652586A1 (de) 1996-12-17 1996-12-17 Dhc-Peptid und Mittel
PCT/EP1997/007090 WO1998027110A2 (de) 1996-12-17 1997-12-17 Dhc-peptid und dieses enthaltendes mittel

Publications (1)

Publication Number Publication Date
DK0946590T3 true DK0946590T3 (da) 2004-07-19

Family

ID=7815068

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97954818T DK0946590T3 (da) 1996-12-17 1997-12-17 Dihydroxypropylcysteinpeptid og middel, der indeholder dette peptid

Country Status (7)

Country Link
US (3) US6573242B1 (da)
EP (1) EP0946590B1 (da)
AT (1) ATE261989T1 (da)
DE (2) DE19652586A1 (da)
DK (1) DK0946590T3 (da)
ES (1) ES2218714T3 (da)
WO (1) WO1998027110A2 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19652586A1 (de) * 1996-12-17 1998-06-18 Biotechnolog Forschung Gmbh Dhc-Peptid und Mittel
DE19822820A1 (de) * 1998-05-20 1999-11-25 Biotechnolog Forschung Gmbh Pharmazeutisches Präparat zur Wundbehandlung
DE10048840A1 (de) * 2000-10-02 2002-04-11 Biotechnolog Forschung Gmbh Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren
EP1490106B1 (de) * 2002-04-04 2008-05-28 Helmholtz-Zentrum für Infektionsforschung GmbH Verwendung eines lipopeptids oder lipoproteins als adjuvans bei therapeutischer oder prophylaktischer vakzinierung
EP1382352A1 (de) * 2002-07-19 2004-01-21 GBF Gesellschaft für Biotechnologische Forschung mbH Bisacyloxypropylcystein-Konjugate und deren Verwendung
DE102009034779A1 (de) 2009-07-25 2011-02-03 Emc Microcollections Gmbh Synthetische Analoga bakterieller Lipopeptide und ihre Anwendung zur Therapie und Prophylaxe allergischer Erkrankungen
EP2305283A1 (en) 2009-09-24 2011-04-06 Helmholtz-Zentrum für Infektionsforschung GmbH Pharmaceutical compositions for treating dysregulated inflammatory diseases
PH12012501596A1 (en) 2010-02-24 2017-02-03 Arrowhead Res Corporation Compositions for targeted delivery of sirna
US20130259928A1 (en) 2010-09-30 2013-10-03 Franvax S.R.L. Generation of virosome particles
DE102011018499A1 (de) 2011-04-23 2012-10-25 Emc Microcollections Gmbh Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950542A (en) * 1967-02-21 1976-04-13 L'oreal Cysteamine derivatives for oral treatment of seborrhea
EP0014815A3 (de) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
US5179079A (en) * 1986-12-16 1993-01-12 Novo Nordisk A/S Nasal formulation and intranasal administration therewith
US5583198A (en) * 1989-12-22 1996-12-10 Commonwealth Scientific And Industrial Research Organization Amino acids, peptides or derivatives thereof coupled to fats
ZA92943B (en) * 1991-02-11 1992-11-25 Porro Massimo Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock
DE4119856A1 (de) * 1991-06-17 1992-12-24 Hoechst Ag N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
US5214062A (en) * 1992-04-08 1993-05-25 Clintec Nutrition Co. Method and composition for treating immune disorders, inflammation and chronic infections
EP0604945A1 (en) * 1992-12-28 1994-07-06 Takeda Chemical Industries, Ltd. TAN-1511, its derivatives, production and use thereof
JP3735388B2 (ja) * 1994-06-03 2006-01-18 エム バイオ テック株式会社 新規グリセロ糖リン脂質とその抗体及びマイコプラズマの検出法
US5856444A (en) * 1994-11-30 1999-01-05 Chugai Seiyaku Kabushiki Kaisha Thrombocytopoiesis stimulating factor
US5788962A (en) * 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
US5817461A (en) * 1996-01-03 1998-10-06 Hamilton Civic Hospitals Research Development Inc. Methods and compositions for diagnosis of hyperhomocysteinemia
US20020155117A1 (en) * 1996-04-04 2002-10-24 Nicole Suciu-Foca Method for detecting organ allograft rejection and uses thereof
DE19652586A1 (de) * 1996-12-17 1998-06-18 Biotechnolog Forschung Gmbh Dhc-Peptid und Mittel
US6506892B1 (en) * 1997-10-29 2003-01-14 Andrew C. Webb Polynucleotides encoding a mycoplasma protein involved in cell growth regulation
DE19822820A1 (de) * 1998-05-20 1999-11-25 Biotechnolog Forschung Gmbh Pharmazeutisches Präparat zur Wundbehandlung
DE10048840A1 (de) * 2000-10-02 2002-04-11 Biotechnolog Forschung Gmbh Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren
EP1490106B1 (de) * 2002-04-04 2008-05-28 Helmholtz-Zentrum für Infektionsforschung GmbH Verwendung eines lipopeptids oder lipoproteins als adjuvans bei therapeutischer oder prophylaktischer vakzinierung
EP1382352A1 (de) * 2002-07-19 2004-01-21 GBF Gesellschaft für Biotechnologische Forschung mbH Bisacyloxypropylcystein-Konjugate und deren Verwendung
EP1484064A1 (en) * 2003-06-04 2004-12-08 Gesellschaft für Biotechnologische Forschung Therapeutical composition containing dentritic cells and use thereof

Also Published As

Publication number Publication date
WO1998027110A2 (de) 1998-06-25
ES2218714T3 (es) 2004-11-16
US20030220265A1 (en) 2003-11-27
WO1998027110A3 (de) 1998-09-11
DE59711429D1 (de) 2004-04-22
DE19652586A1 (de) 1998-06-18
ATE261989T1 (de) 2004-04-15
US20130178412A1 (en) 2013-07-11
US6573242B1 (en) 2003-06-03
US7435790B2 (en) 2008-10-14
EP0946590A2 (de) 1999-10-06
EP0946590B1 (de) 2004-03-17

Similar Documents

Publication Publication Date Title
DK0728148T3 (da) Forbedrede immunogene sammensætninger mod humant gastrin 17
ES2176284T3 (es) Amidas de peptidos inhibidoras del cancer de seres humanos.
NO940288L (no) Formuleringer inneholdende umettede fettsyrer
CA2270289A1 (en) Proteins with enhanced levels of essential amino acids
DE69531204D1 (de) Formulierungen fuer faktor ix
CA2252436A1 (en) Process for the manufacture of surfactants containing branch chain alkyl groups
AU631681B2 (en) Radiolabeled anticoagulant peptides
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
MX9605359A (es) Composiciones para la limpieza de telas que contienen variantes de subtilicina bpn.
IL128829A0 (en) Improved solid-phase peptide and agent for use in such synthesis
NZ503007A (en) Conjugates that contain the homeodomain of antennapedia
ES2182908T3 (es) Nuevos peptidos.
MX9605357A (es) Variantes de subtilisina bpn' que tiene absorcion reducida e hidrolisis incrementada.
RU94045952A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена
DK1161449T3 (da) Modulatorer af beta-amyloidpeptidaggregering, der omfatter d-aminosyrer
BG103968A (en) Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity
ATE261989T1 (de) Dhc-peptid und dieses enthaltendes mittel
DE69525740D1 (de) Spezielle halofantrinhaltige Zusammensetzungen
NO971621L (no) Keratinocyttvekstfaktoranaloger
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
WO1999014241A3 (en) Compositions and methods for the treatment of immune related diseases
JO1677B1 (en) 3,3 'compounds - dithiobase (prepernic acid) and its organic salts
DE69333952D1 (de) Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen.
MX9806041A (es) Proteina purificada sr-p70.
BG100248A (bg) Инхибитори на скваленсинтетаза